Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Pfizer's portfolio includes new early-stage compounds for MED

Nov. 23, 1999

Anthranilic acid derivatives from Fujisawa particularly useful for erectile dysfunction

Nov. 22, 1999

Chronic oral treatment with SR-121463 improves water retention in cirrhotic rats

Nov. 16, 1999

VPA-985 as a novel treatment option for hyponatremia in cirrhosis: clinical results

Nov. 15, 1999

Preclinical data reported at ASN support utility of OP-1 in treating renal disease

Nov. 12, 1999

Novel agents for renal diseases with benzimidazole structure

Nov. 11, 1999

NeXstar research leads to identification of new target for treating renal disease

Nov. 11, 1999

P-selectin blocker SKK-60037 may help prevent progressive renal injuries

Nov. 9, 1999

Selectin ligand antagonist TBC-1269 attenuates renal ischemic reperfusion injury in rats

Nov. 9, 1999

Vasopressin antagonist VPA-985: summary of clinical data presented at ASN

Nov. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...